Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Data & Figures
Ordering
Resources
Publications
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
Partners
Heading &
Sub-heading can be edited through HQI
About Us
>
Partners
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Partners
Global joint Marketing Agreement with
Promega Corporation
for INOVIQ’s EXO-NET exosome capture technology and Promega Nucleic Acid purification systems to provide exosome solutions for EV isolation, biomarker discovery and diagnostics development.
License and Supply Agreement with
ResearchDx
for INOVIQ’s EXO-NET® pan-exosome capture product to provide EXO-NET enabled high-throughput exosome isolation, biomarker discovery and diagnostics development services in the USA.
Master Service Agreement to provide contract research services to develop and validate INOVIQ’s SubB2M tests for detection of breast and ovarian cancers.
Master Manufacturing Agreement with Singapore-based
MP Biomedicals
for contract manufacture of cGMP-grade SubB2M protein for INOVIQ’s SubB2M tests.
The
University of Queensland Research
and Option Agreement with UniQuest for EXO-NET enabled exosome isolation and biomarker identification, and development of an earlier detection test for ovarian cancer.
Griffith University Institute for Glycomics
collaborative Research Agreement for development of SubB2M pan-cancer probe assays for detection of a range of cancers.
Percorso Life Sciences
Service Agreement to provide US-based contract sales and logistics services for INOVIQ products.